Global Blood Based Biomarkers Market Size & Outlook
Global blood based biomarkers market, 2018-2030 (US$M)
Related Markets
Global blood based biomarkers market highlights
- The global blood based biomarkers market generated a revenue of USD 7,852.1 million in 2024 and is expected to reach USD 11,581.8 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 7.2% by 2030.
- In terms of segment, genetic biomarkers accounted for a revenue of USD 2,790.7 million in 2024.
- Cell-Based Biomarkers is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 7,852.1 million |
| Market revenue in 2030 | USD 11,581.8 million |
| Growth rate | 7.2% (CAGR from 2025 to 2030) |
| Largest segment | Genetic biomarkers |
| Fastest growing segment | Cell-Based Biomarkers |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Genetic Biomarkers, Protein Biomarkers, Metabolic Biomarkers, Cell-Based Biomarkers, Epigenetic Biomarkers |
Other key industry trends
- In terms of revenue, the North America accounted for 42.8% of the global blood based biomarkers market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 534.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Based Biomarkers Market Scope
Blood Based Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Cleveland-Cliffs Inc | View profile | 28000 | 200 Public Square, Suite 3300, Cleveland, OH, United States, 44114-2315 | https://www.clevelandcliffs.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Global blood based biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood based biomarkers market will help companies and investors design strategic landscapes.
Genetic biomarkers was the largest segment with a revenue share of 35.54% in 2024. Horizon Databook has segmented the Global blood based biomarkers market based on genetic biomarkers, protein biomarkers, metabolic biomarkers, cell-based biomarkers, epigenetic biomarkers covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Blood Based Biomarkers Type Outlook (Revenue, USD Million, 2018-2030)
- Cell-Based Biomarkers
- Protein Biomarkers
- Metabolic Biomarkers
- Epigenetic Biomarkers
- Genetic Biomarkers
- Global Blood Based Biomarkers Application Outlook (Revenue, USD Million, 2018-2030)
- Cancer
- Cardiovascular Diseases
- Others
- Neurological Diseases
- Immunological Diseases
- Global Blood Based Biomarkers Technology Outlook (Revenue, USD Million, 2018-2030)
- Next-Generation Sequencing
- Others
- Polymerase Chain Reaction
- Immunoassays
- Mass Spectrometry
- Global Blood Based Biomarkers End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Clinics
- Research & Academic Institutes
- Others
- Diagnostic Laboratories
Reasons to subscribe to Global blood based biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global blood based biomarkers market databook
-
Our clientele includes a mix of blood based biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global blood based biomarkers market , including forecasts for subscribers. This global databook contains high-level insights into Global blood based biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global blood based biomarkers market size, by regions, 2018-2030 (US$M)
Top 10 countries: Blood based biomarkers market size, 2024 (US$M)
Global blood based biomarkers market share, by end use, 2024 & 2030 (%, US$M)
Blood based biomarkers market: Opportunity assessment by country
Global blood based biomarkers market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
